Terms ending in 2041
Roche Sequencing Solutions, Inc.
Every in-force patent on Roche Sequencing Solutions, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,970,731 | Enhancement of Nucleic Acid Polymerization by Aromatic Compounds In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,698,523 | Enhancement of Nucleic Acid Polymerization by Aromatic Compounds In force · Low confidence | Roche Sequencing Solutions, Inc. | In force | Low confidence | |
| US 12,116,570 | Directed Evolution of Enzymes by Plasmid Tagging in Droplets In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,226,766 | Removing and Reinserting Protein Nanopores in a Membrane Using Osmotic Imbalance In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,913,062 | System and Method for Isolation and Qualification of Nucleic Acids In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,929,147 | Direct Variant Phasing in Long Reads to Detect Quasispecies In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,976,275 | Generation of Double-Stranded DNA Templates for Single Molecule Sequencing In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,898,204 | Generation of Single-Stranded Circular DNA Templates for Single Molecule Sequencing In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,071,661 | Method of Predicting Response to Therapy by Assessing Tumor Genetic Heterogeneity In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,123,866 | Nanopore Sequencing Device Comprising Ruthenium-Containing Electrodes In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| 9 more term ends in 2041 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
18 of these are in force and held by Roche Sequencing Solutions, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.